Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
21.15
-0.65 (-2.98%)
At close: Jul 31, 2026, 4:00 PM EDT
21.24
+0.09 (0.45%)
After-hours: Jul 31, 2026, 7:56 PM EDT
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $1.15 billion as of July 31, 2026. Its market cap has increased by 309.49% in one year.
Market Cap
1.15B
Enterprise Value
657.45M
1-Year Change
309.49%
Ranking
Category
Stock Price
$21.15
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $1.15B, a decrease of -11.78%. That is a compound annual growth rate of -2.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.15B | 126.28% |
| Dec 31, 2025 | 506.46M | 266.35% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wave Life Sciences | 1.12B |
| LB Pharmaceuticals | 1.12B |
| Corvus Pharmaceuticals | 1.10B |
| MeiraGTx Holdings | 1.08B |
| Cullinan Therapeutics | 1.06B |
| Inventiva | 1.06B |
| Seaport Therapeutics | 1.06B |
| Alto Neuroscience | 1.04B |